Anti-glycolipid antibodies in the diagnosis of autoimmune neuropathies

Revue Neurologique

Volumn 158, Issue 12 II, 2002, Pages

  Willison, H J ^a  

^a SOUTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; GANGLIOSIDE GD 1A; GANGLIOSIDE GD 1B; GANGLIOSIDE GM1; GLOBOSIDE; GLYCOLIPID; GLYCOLIPID ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY; MYELIN ASSOCIATED GLYCOPROTEIN; SULFATED GLUCURONYL (LACTOSAMINYL)PARAGLOBOSIDE; UNCLASSIFIED DRUG; ACID BETA GALACTOSIDASE; ACID BETA-GALACTOSIDASE; BETA GALACTOSIDASE; GANGLIOSIDE; GANGLIOSIDE, GD1A; GANGLIOSIDE, GD1B; GQ1B GANGLIOSIDE; SULFATE 3 GLUCURONYL PARAGLOBOSIDE; SULFATE-3-GLUCURONYL PARAGLOBOSIDE;

ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ANTIGEN BINDING; ATAXIA; AUTOIMMUNE DISEASE; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; EPITOPE MAPPING; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNOASSAY; MOTOR NEURON DISEASE; MOTOR NEUROPATHY; NEUROPATHY; PARAPROTEINEMIA; PATHOPHYSIOLOGY; REACTION ANALYSIS; SENSORY DYSFUNCTION; SERODIAGNOSIS; SYNDROME DELINEATION; ACUTE DISEASE; ARTICLE; CHRONIC DISEASE; IMMUNOLOGY; NEUROLOGIC DISEASE;

ACUTE DISEASE; ANTIBODIES; AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM; BETA-GALACTOSIDASE; CHRONIC DISEASE; GANGLIOSIDES; GLOBOSIDES; HUMANS;

EID: 0038176920     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (24)

1. Ang CW, Jacobs BC, Brandenburg AH, et al. (2000). Cross-reactive antibodies against GM2 and CMV-infected fibroblasts in Guillain-Barré syndrome. Neurology, 54(7): 1453-1458.
2. Carpo M, Pedotti R, Allaria S, et al. (1999). Clinical presentation and outcome of Guillain-Barré and related syndromes in relation to anti-ganglioside antibodies. J Neurol Sci, 168: 78-84.
3. Chida K, Nomura H, Konno H, Takase S, Itoyama Y. (1999). Recurrent Miller Fisher syndrome: Clinical and laboratory features and HLA antigens. J Neurol Sci, 165: 139-143.
4. Fisher M. (1956). An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia). N Engl J Med, 255: 57-65.
5. Hahn AF. (1998). Guillain-Barré syndrome. Lancet, 352: 635-641.
6. Ho TW, Willison HJ, Nachamkin J, et al. (1999). Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barré syndrome. Ann Neurol, 45: 168-173.
7. Kaida K, Kusunoki S, Kamakura K, Motoyoshi K, Kanazawa J. (2000). Guillain-Barré syndrome with antibody to a ganglioside, N-acetylgalactosaminyl GD1a. Brain, 123: 116-124.
8. Koga M, Ang CW, Yuki N, et al. (2001). Comparative study of preceding Campylobacter jejuni infection in Guillain-Barré syndrome in Japan and The Netherlands. J Neurol Neurosurg Psychiatry, 70(5): 693-695.
9. Kornberg AJ, Pestronk A. (1995). Chronic motor neuropathies: Diagnosis, therapy, and pathogenesis. Ann Neuro, 37(S1): S43-50.
10. Kusunoki S. (2000). Antiglycolipid antibodies in Guillain-Barré syndrome and autoimmune neuropathies. Am J Med Sci, 319: 23.
11. Kusunoki S, Chiba A, Kanazawa J. (1999). Anti-GQ1b IgG antibody is associated with ataxia as well as ophthalmoplegia. Muscle Nerve, 22: 1071-1074.
12. Kusunoki S, Shiina M, Kanazawa I. (2001). Anti-Gal-C antibodies in GBS subsequent to mycoplasma infection: Evidence of molecular mimicry. Neurology, 57(4): 736-738.
13. McKhann GM, Cornblath DR, Griffin JW, et al. (1993). Acute motor axonal neuropathy - A frequent cause of acute flaccid paralysis in China. Ann Neurol, 33: 333-342.
14. O'Leary C, Willison HJ. (2000). The role of antiglycolipid antibodies in peripheral neuropathies. Current Opinion in Neurology, 13: 583-588.
15. Pan CL, Yuki N, Koga M, Chiang MC, Hsieh ST. (2001). Acute sensory ataxic neuropathy associated with monospecific anti-GD1b IgG antibody. Neurology, 57: 1316-1318.
16. Quarles RH, Weiss MD. (1999). Autoantibodies associated with peripheral neuropathy. Muscle Nerve, 22: 800-822.
17. Schwerer B, Neisser A, Bernheimer H. (1999). Distinct immunoglobulin class and immunoglobulin G subclass patterns against ganglioside GQ1b in Miller Fisher syndrome following different types of infection. Infection Immunity, 67: 2414-2420.
18. Willison HJ, O'Hanlon GM. (1999). The immunopathogenesis of Miller Fisher syndrome. J Neuroimmunol, 100: 3-12.
19. Willison HJ, Veitch J, Swan AV, et al. (1999). Inter-laboratory validation of an ELISA for the determination of serum anti-ganglioside antibodies. Eur J Neurol, 6: 71-77.
20. Willison HJ, O'Leary CP, Veitch J, et al. (2001) The clinical and laboratory features of chronic sensory ataxic neuropathy with anti-disialosyl IgM antibodies. Brain, 124: 1968-1977.
21. Yako K, Kusunoki S, Kanazawa I. (1999). Serum antibody against a peripheral nerve myelin ganglioside, LM1, in Guillain-Barré syndrome. J Neurol Sci, 168: 85-89.
22. Yuki N. (1998) Anti-ganglioside antibody and neuropathy: Review of our research. J Periph Nerv Sys, 3: 3-18.
23. Yuki N, Ho TW, Tagawa Y, et al. (1999). Autoantibodies to GM1b and GalNAc-GD1a: Relationship to Campylobacter jejuni infection and acute motor axonal neuropathy in China. J Neurol Sci, 164: 134-138.
24. Yuki N. (2001). Infectious origins of, and molecular mimicry in, Guillain-Barré and Fisher syndromes. Lancet Infectious Diseases, 1: 29-37.